|
HCV | Abstract Library |
 |
|
The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
2. | Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population-based pre-exposure prophylaxis program in British Columbia, Canada |
|
Liver Int. 2022 Jul;42(7):1528-1535. doi: 10.1111/liv.15237. Epub 2022 Mar 28.
Kyle A Thompson 1, Gabriel Blank 2, Junine Toy 1, David M Moore 1 2, Nathan Lachowsky 3, Nicanor Bacani 1, Wendy Zhang 1, Paul Sereda 1, Viviane D Lima 1 2, Rolando Barrios 1, Julio S G Montaner 1 2, Mark W Hull 1 2
|
|
|
3. | Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R) |
|
Viruses. 2022 Jul 14;14(7):1541. doi: 10.3390/v14071541.
Markus Cornberg 1, Albrecht Stoehr 2, Uwe Naumann 3, Gerlinde Teuber 4, Hartwig Klinker 5, Thomas Lutz 6, Hjördis Möller 7, Dennis Hidde 8, Kristina Lohmann 8, Karl-Georg Simon 9
|
|
|
|
|
|
|
|
|
7. | Hepatitis C virus (HCV) seroprevalence, RNA detection, and genotype distribution across Florida, 2015-2018 |
|
Prev Med. 2022 Aug;161:107136. doi: 10.1016/j.ypmed.2022.107136. Epub 2022 Jul 5.
Brittney L Dickey 1, Anna E Coghill 1, Julie A Rathwell 1, Richard R Reich 2, Susan T Vadaparampil 3, Shannon M Christy 4, Richard Roetzheim 5, Elizabeth Shenkman 6, Anna R Giuliano 7
|
|
|
|
|
9. | Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication |
|
J Hepatol. 2022 Jul;77(1):55-62. doi: 10.1016/j.jhep.2022.01.027. Epub 2022 Feb 12.
Peter P Mueller 1, Qiushi Chen 2, Turgay Ayer 3, Gizem S Nemutlu 1, Ali Hajjar 1, Emily D Bethea 4, Mary Linton B Peters 5, Brian P Lee 6, Naveed Z Janjua 7, Fasiha Kanwal 8, Jagpreet Chhatwal 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17. | Hepatitis C coinfection and extrahepatic cancer incidence among people living with HIV |
|
HIV Med. 2022 Jul;23(6):620-628. doi: 10.1111/hiv.13218. Epub 2021 Dec 23.
Sarah J Willis 1, H Nina Kim 2, Chad J Achenbach 3, Edward R Cachay 4, Katerina A Christopoulos 5, Heidi M Crane 2, Ricardo A Franco 6, Christopher B Hurt 7, Mari M Kitahata 2, Richard D Moore 8, Michael J Silverberg 9, Phyllis C Tien 5 10, Daniel Westreich 11, Julia L Marcus 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25. | Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression |
|
Lancet HIV. 2022 Jun;9(6):e414-e427.doi: 10.1016/S2352-3018(22)00077-7.
Samira Hosseini-Hooshyar 1, Behzad Hajarizadeh 2, Sahar Bajis 2, Matthew Law 2, Naveed Z Janjua 3, Daniel S Fierer 4, David Chromy 5, Jürgen K Rockstroh 6, Thomas C S Martin 7, Patrick Ingiliz 8, Chien-Ching Hung 9, Gregory J Dore 2, Marianne Martinello 2, Gail V Matthews 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36. | Hepatitis C Virus Reflex Testing Protocol in an Emergency Department |
|
West J Emerg Med. 2022 Feb 28;23(2):108-114. doi: 10.5811/westjem.2021.10.52468.
Jacob J Manteuffel 1, Madison S Lee 1, Rebecca M Bussa 1, Noor L Sabagha 1, Kaleem Chaudhry 1, Jacob E Ross 1, Megan R Cook 1, Jo-Ann K Rammal 1, Karthik Sridasyam 1, Howard A Klausner 1, Linoj P Samuel 2, Joseph B Miller 1
|
|
|
37. | Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study |
|
Eur J Neurol. 2022 Feb;29(2):400-412. doi: 10.1111/ene.15138. Epub 2021 Nov 2.
Luis Ibáñez-Samaniego 1 2 3, Marta Rapado-Castro 4 5 6, Lucia Cabrero 2 3, Cristina Navarrete 1, Seila García-Mulas 1, Adriana Ahumada 1, Laura Marquez 1, Maria Dolores Pérez 1, Diego Rincon 1 2 3 6, Rafael Bañares 1 2 3 6, Rita Garcia-Martinez 2 3 6 7
|
|
|
|
|
|
|
|
|
|
|
|
|
43. | Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice |
|
World J Gastroenterol. 2022 Mar 28;28(12):1226-1238.doi: 10.3748/wjg.v28.i12.1226.
Nadia Marascio 1, Salvatore Rotundo 2, Angela Quirino 1, Giovanni Matera 1, Maria Carla Liberto 1, Chiara Costa 2, Alessandro Russo 2, Enrico Maria Trecarichi 2, Carlo Torti 3
|
|
|
|
|
|
|
46. | Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial |
|
Aliment Pharmacol Ther. 2022 Jun;55(12):1512-1523.doi: 10.1111/apt.16953. Epub 2022 May 10.
Christopher J Byrne 1 2, Andrew Radley 3, Sarah K Inglis 2, Lewis Beer 2, Nicki Palmer 4, Minh Duc Pham 5 6, Kate Allardice 6, Huan Wang 7, Emma Robinson 8, Monika Hermansson 9, Dimitri Semizarov 9, Brendan Healy 4, Joseph S Doyle 5 6, John F Dillon 1 8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53. | Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use |
|
Antimicrob Chemother. 2022 Apr 27;77(5):1396-1403.doi: 10.1093/jac/dkac051.
Kristina M Brooks 1, Jose R Castillo-Mancilla 2, Mary Morrow 3, Samantha Mawhinney 3, Sarah E Rowan 2 4, David Wyles 2 4, Joshua Blum 4, Ryan Huntley 1, Lana Salah 1, Arya Tehrani 1, Leah C Jimmerson 1, Laura Roon 1, Lane R Bushman 1, Peter L Anderson 1, Jennifer J Kiser 1
|
|
|
|
|
|
|
56. | A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial |
|
Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317.doi: 10.1016/S2468-1253(21)00397-6. Epub 2022 Jan 10.
Sunil S Solomon 1, Sandra Wagner-Cardoso 2, Laura Smeaton 3, Leonard A Sowah 4, Chanelle Wimbish 5, Gregory Robbins 6, Irena Brates 3, Christine Scello 7, Annie Son 8, Anchalee Avihingsanon 9, Benjamin Linas 10, Donald Anthony 11, Estevão Portela Nunes 2, Dimas A Kliemann 12, Khuanchai Supparatpinyo 13, Cissy Kityo 14, Pablo Tebas 15, Jaclyn Ann Bennet 16, Jorge Santana-Bagur 17, Constance A Benson 18, Marije Van Schalkwyk 19, Nelson Cheinquer 8, Susanna Naggie 20, David Wyles 21, Mark Sulkowski 22
|
|
|
|
|
58. | Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic Response |
|
Clin Gastroenterol Hepatol. 2022 Feb;20(2):438-446.doi: 10.1016/j.cgh.2021.01.026. Epub 2021 Jan 22.
Zobair M Younossi 1, Andrei Racila 2, Andrew Muir 3, Marc Bourliere 4, Alessandra Mangia 5, Rafael Esteban 6, Stefan Zeuzem 7, Massimo Colombo 8, Michael Manns 9, George V Papatheodoridis 10, Maria Buti 6, Anand Chokkalingam 11, Anuj Gaggar 11, Fatema Nader 12, Issah Younossi 12, Linda Henry 12, Maria Stepanova 12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70. | Individualized Provider Feedback Increased HIV and HCV Screening and Identification in a New York City Emergency Department |
|
AIDS Patient Care STDS. 2022 Mar;36(3):106-114. doi: 10.1089/apc.2021.0225.
Jason Zucker 1, Lawrence Purpura 1 2, Fereshteh Sani 3, Simian Huang 1, Aaron Schluger 4, Kenneth Ruperto 5, Jacek Slowkowski 5, Susan Olender 1, Matt Scherer 1, Delivette Castor 1, Peter Gordon 1
|
|
|
|
|
72. | A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study |
|
Hepatology. 2021 Dec;74(6):2952-2964.doi: 10.1002/hep.32053.Epub 2021 Aug 26.
Mark S Sulkowski 1, Juhi S Moon 1, Kenneth E Sherman 2, Giuseppe Morelli 3, Jama M Darling 4, Andrew J Muir 5, Mandana Khalili 6, Dawn A Fishbein 7, Federico Hinestrosa 8, Mitchell L Shiffman 9, Adrian Di Bisceglie 10, K Rajender Reddy 11, Brian Pearlman 12, Anna S Lok 13, Michael W Fried 4, Paul W Stewart 14, Joy Peter 3, Summer Wadsworth 15, Scott Kixmiller 16, Anquenette Sloan 17, Monika Vainorius 4, Patrick M Horne 3, Larry Michael 14, Meichen Dong 14, Donna M Evon 4, Jodi B Segal 18, David R Nelson 3, PRIORITIZE Study Team
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79. | Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination |
|
Liver Int. 2022 Feb 27. doi: 10.1111/liv.15216. Online ahead of print.
Roberta D'Ambrosio 1, Giuliano Rizzardini 2, Massimo Puoti 3, Stefano Fagiuoli 4, Maria Paola Anolli 1, Claudia Gabiati 5, Federico D'Amico 3, Luisa Pasulo 4, Umberto Restelli 6 7, Massimo Colombo 8, Pietro Lampertico 1 9
|
|
|
|
|
|
|
82. | Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up study |
|
Liver Int. 2022 Feb 26. doi: 10.1111/liv.15211. Online ahead of print.
Fred Poordad 1, Franco Felizarta 2, Betty B Yao 3, J Scott Overcash 4, Tarek Hassanein 5, Kosh Agarwal 6, Edward Gane 7, David Shaw 8, Michael Waters 4, Preethi Krishnan 3, Andrew Topp 3, Margaret Burroughs 3, Frederik Nevens 9
|
|
|
|
|
|
|
|
|
86. | Removal of medicaid restrictions were associated with increased hepatitis C virus treatment rates, but disparities persist |
|
J Viral Hepat. 2022 Mar 7. doi: 10.1111/jvh.13661. Online ahead of print.
Lauren D Nephew 1 2, Yumin Wang 3, Kawthar Mohamed 4, Deborah Nichols 5, Susan M Rawl 2 6, Eric Orman 1, Archita P Desai 1, Kavish R Patidar 1, Marwan Ghabril 1, Naga Chalasani 1, Monica L Kasting 2 7
|
|
|
|
|
88. | Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy |
|
PLoS One. 2022 Mar 23;17(3):e0265811. doi: 10.1371/journal.pone.0265811. eCollection 2022.
Kiana Yazdani 1, Katerina Dolguikh 1, Wendy Zhang 1, Sara Shayegi-Nik 1 2, Jessica Ly 1, Shaughna Cooper 1, Jason Trigg 1, Sophia Bartlett 3 4, Rolando Barrios 1 3, Julio S G Montaner 1, Kate Salters 1 5
|
|
|
|
|
|
|
91. | The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study |
|
J Viral Hepat. 2022 Mar 11. doi: 10.1111/jvh.13664. Online ahead of print.
Jessica Howell 1 2 3 4, Michael W Traeger 1 2, Bridget Williams 1, Chloe Layton 5, Joseph S Doyle 1 6, Ned Latham 1 7, Bridget Draper 1 2, Frances Bramwell 5, Dean Membrey 5, Maggie Mcpherson 8, Janine Roney 9, Mark Stoové 1, Alexander J Thompson 3 4, Margaret E Hellard 1 2 6 10, Alisa Pedrana 1 2
|
|
|
92. | Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis |
|
Lancet Gastroenterol Hepatol. 2022 Mar 15;S2468-1253(21)00471-4.doi: 10.1016/S2468-1253(21)00471-4. Online ahead of print.
Evan B Cunningham 1, Alice Wheeler 2, Behzad Hajarizadeh 2, Clare E French 3, Rachel Roche 4, Alison D Marshall 5, Guillaume Fontaine 6, Anna Conway 5, Braulio M Valencia 2, Sahar Bajis 2, Justin Presseau 7, John W Ward 8, Louisa Degenhardt 9, Gregory J Dore 2, Matthew Hickman 10, Peter Vickerman 10, Jason Grebely 2
|
|
|
|
|
|
|
95. | Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral based treatment regimens: evidence from a global dataset |
|
J Viral Hepat. 2022 Mar 12. doi: 10.1111/jvh.13672. Online ahead of print.
Jake R Morgan 1, Elizabeth Marsh 2, Alexandra Savinkina 2, Sonjelle Shilton 3, Shaun Shadaker 4, Tengiz Tsertsvadze 5, George Kamkamidze 6, Maia Alkhazashvili 7, Tim Morgan 8, Pam Belperio 8, L Backus 8, Waheed Doss 9, Gamal Esmat 9, Mohamed Hassany 9, Aisha Elsharkawy 9, Wafaa Elakel 9, Mai Mehrez 9, Graham R Foster 10, Kinge Wose 11, Kara W Chew 12, Charles S Chasela 13, Ian M Sanne 14, Yin M Thanung 15, Anne Loarec 16, Khawar Aslam 17, Suna Balkan 18, Philippa J Easterbrook 19, Benjamin P Linas 2 20
|
|
|
|
|
|
|
|
|
|
|
100. | Effect of a Default Order vs an Alert in the Electronic Health Record on Hepatitis C Virus Screening Among Hospitalized Patients: A Stepped-Wedge Randomized Clinical Trial |
|
JAMA Netw Open. 2022 Mar 1;5(3):e222427. doi: 10.1001/jamanetworkopen.2022.2427.
Shivan J Mehta 1 2, Jessie Torgersen 1, Dylan S Small 3, Colleen P Mallozzi 4 5, John D McGreevey 3rd 1 4 5, Charles A L Rareshide 1 6, Chalanda N Evans 1 6, Mika Epps 4, David Stabile 4, Christopher K Snider 2 6, Mitesh S Patel 1 3 6 7 8
|
|
|
|
|
102. | Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 |
|
Epidemiol Infect. 2021 Dec 6;150:e7. doi: 10.1017/S0950268821002624.
Anna Lee Wilkinson 1 2, Alisa Pedrana 1 2, Michael W Traeger 1 2, Jason Asselin 1, Carol El-Hayek 1, Long Nguyen 1, Victoria Polkinghorne 1, Joseph S Doyle 1 3, Alexander J Thompson 4 5, Jessica Howell 1 2 4 5, Nick Scott 1 2, Wayne Dimech 6, Rebecca Guy 7, Margaret Hellard 1 2 3 8, Mark Stoové 1 2, EC Victoria Partnership and the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of blood-borne viruses AND sexually transmissible infections (ACCESS)
|
|
|
|
|
|
|
|
|
106. | Microelimination of Hepatitis C Among People With Human Immunodeficiency Virus Coinfection: Declining Incidence and Prevalence Accompanying a Multicenter Treatment Scale-up Trial |
|
Clin Infect Dis. 2021 Oct 5;73(7):e2164-e2172. doi: 10.1093/cid/ciaa1500.
Joseph S Doyle 1 2, Daniela K van Santen 1 3, David Iser 2 4, Joe Sasadeusz 2 5, Mark O'Reilly 6, Brendan Harney 1 2, Michael W Traeger 1 3, Janine Roney 2, Julia C Cutts 1, Anna L Bowring 1, Rebecca Winter 1 4, Nick Medland 7, Christopher K Fairley 7, Richard Moore 8, B K Tee 9, Jason Asselin 1, Carol El-Hayek 1, Jennifer F Hoy 2, Gail V Matthews 10, Maria Prins 11 12, Mark A Stoové 1 3, Margaret E Hellard 1 2 3 13
|
|
|
|
|
108. | Sofosbuvir and risk of estimated glomerular filtration rate decline or end-stage renal disease in patients with renal impairment |
|
Aliment Pharmacol Ther. 2022 Mar 2. doi: 10.1111/apt.16830. Online ahead of print.
Mark Sulkowski 1, Laura E Telep 2, Massimo Colombo 3, Francois Durand 4, K Rajender Reddy 5, Eric Lawitz 6, Marc Bourlière 7 8, Nelson Cheinquer 2, Stacey Scherbakovsky 2, Liyun Ni 2, Lindsey Force 2, Heribert Ramroth 2, Anuj Gaggar 2, Anand P Chokkalingam 2, Meghan E Sise 9
|
|
|
109. | Outcomes of community-based hepatitis C treatment by general practitioners and nurses in Australia through remote specialist consultation |
|
Intern Med J. 2021 Nov;51(11):1927-1934. doi: 10.1111/imj.15037. Epub 2021 Oct 28.
James Haridy 1 2 3, Guru Iyngkaran 1 2 4, Amanda Nicoll 1 3 5, Kate Muller 6, Mark Wilson 7, Alan Wigg 6, Jeyamani Ramachandran 6, Renjy Nelson 8 9, Stephen Bloom 3 5, Joseph Sasadeusz 10, Sally Watkinson 10, Anton Colman 11, Rosalie Altus 6, Emma Tilley 6, Jeffrey Stewart 6 9, Geoff Hebbard 2, Danny Liew 12, Edmund Tse 8 11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
118. | Sofosbuvir-Velpatasvir-Voxilaprevir in Adolescents 12 to 17 Years Old With Hepatitis C Virus Infection |
|
Hepatology. 2022 Feb 3. doi: 10.1002/hep.32393. Online ahead of print.
Guiseppe Indolfi 1, Deirdre Kelly 2, Gabriella Nebbia 3, Raffaele Iorio 4, Anna Mania 5, Vania Giacomet 6, Leszek Szenborn 7, Jiang Shao 8, Mun Sang Yue 8, Chia-Hsiang Hsueh 8, Bandita Parhy 8, Kathryn Kersey 8, Alessandra Mangia 9, Malgorzata Pawlowska 10, Sanjay Bansal 11
|
|
|
|
|
|
|
|
|
122. | Lower rates of emergency visits and hospitalizations among chronic hepatitis C patients with sustained virological response to interferon-free direct-acting antiviral therapy (2014-2018) |
|
Clin Infect Dis. 2022 Feb 11;ciac124. doi: 10.1093/cid/ciac124. Online ahead of print.
Stuart C Gordon 1, Eyasu H Teshale 2, Philip R Spradling 2, Anne C Moorman 2, Joseph A Boscarino 3, Mark A Schmidt 4, Yihe G Daida 5, Loralee B Rupp 6, Sheri Trudeau 7, Jiaqi Zhang 7, Mei Lu 7, CHeCS Investigators
|
|
|
123. | Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-stratification in Patients with Hepatitis C Cirrhosis |
|
Clin Transl Gastroenterol. 2022 Feb 9. doi: 10.14309/ctg.0000000000000462.Online ahead of print.
Hamish Innes 1 2 3, Alex J Walker 4, Jennifer Benselin 5, Jane I Grove 5, Vincent Pedergnana 6 7, Shang-Kuan Lin 7, John McLauchlan 8, Sharon J Hutchinson 1 3, Eleanor Barnes 7, William L Irving 5, Indra Neil Guha 5, HCV Research UK; & STOP-HCV Consortia; HCV Research UK; & STOP-HCV Consortia
|
|
|
|
|
|
|
126. | A Digital Case-Finding Algorithm for Diagnosed but Untreated Hepatitis C: A Tool for Increasing Linkage to Treatment and Cure |
|
Hepatology. 2021 Dec;74(6):2974-2987. doi: 10.1002/hep.32086.
Brooke Wyatt 1, Ponni V Perumalswami 1 2 3, Anna Mageras 1, Mark Miller 1, Alyson Harty 1, Ning Ma 1, Chip A Bowman 4, Francina Collado 1, Jihae Jeon 1, Lismeiry Paulino 1, Amreen Dinani 1, Douglas Dieterich 1, Li Li 1, Maxence Vandromme 1, Andrea D Branch
|
|
|
|
|
|
|
129. | Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064) |
|
Open Forum Infect Dis. 2021 Jun 27;8(8):ofab334. doi: 10.1093/ofid/ofab334.eCollection 2021 Aug.
Lisa R Metsch 1, Daniel J Feaster 2, Lauren K Gooden 1, Carmen Masson 3, David C Perlman 4, Mamta K Jain 5, Tim Matheson 6, C Mindy Nelson 2, Petra Jacobs 7, Susan Tross 8, Louise Haynes 9, Gregory M Lucas 10, Jonathan A Colasanti 11, Allan Rodriguez 12, Mari-Lynn Drainoni 13, Georgina Osorio 4, Ank E Nijhawan 5, Jeffrey M Jacobson 14, Meg Sullivan 13, David Metzger 15, Pamela Vergara-Rodriguez 16, Ronald Lubelchek 17, Rui Duan 2, Jacob N Batycki 2, Abigail G Matthews 18, Felipe Munoz 18, Eve Jelstrom 19, Raul Mandler 20, Carlos Del Rio 11
|
|
|
|
|
|
|
|
|
133. | Five-Year Follow-Up of Cured HCV Patients under Real-World Interferon-Free Therapy |
|
2021 Jul 22;13(15):3694. doi: 10.3390/cancers13153694.
Robert Flisiak 1, Dorota Zarebska-Michaluk 2, Ewa Janczewska 3, Tadeusz Lapinski 1, Magdalena Rogalska 1, Ewa Karpinska 4, Tomasz Mikula 5, Beata Bolewska 6, Jolanta Bialkowska 7, Katarzyna Flejscher-Stepniewska 8, Krzysztof Tomasiewicz 9, Kornelia Karwowska 10, Monika Pazgan-Simon 11, Anna Piekarska 12, Hanna Berak 13, Olga Tronina 14, Aleksander Garlicki 15, Jerzy Jaroszewicz 16
|
|
|
|
|
|
|
136. | 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs |
|
Addict Sci Clin Pract. 2021 Aug 12;16(1):52. doi: 10.1186/s13722-021-00260-8.
Judith I Tsui 1, Michael P Barry 2 3, Elizabeth J Austin 4 5, Elsa W Sweek 4 5 6, Elyse Tung 7 8, Ryan N Hansen 7 8, Michael Ninburg 9, John D Scott 10, Sara N Glick 11 3, Emily C Williams 5 6
|
|
|
|
|
|
|
|
|
|
|
|
|
142. | Strategic treatment optimization for HCV (STOPHCV1): a randomized controlled trial of ultrashort duration therapy for chronic hepatitis C |
|
Wellcome Open Res. 2021 Jul 29;6:93. doi: 10.12688/wellcomeopenres.16594.2.eCollection 2021.
Graham S Cooke 1 2, Sarah Pett 3 4 5, Leanne McCabe 3, Chris Jones 1 2, Richard Gilson 4 5, Sumita Verma 6, Stephen D Ryder 7, Jane D Collier 8, Stephen T Barclay 9, Aftab Ala 10, Sanjay Bhagani 11, Mark Nelson 12, Chinlye Ch'Ng 13, Ben Stone 14, Martin Wiselka 15, Daniel Forton 16, Stuart McPherson 17, Rachel Halford 18, Dung Nguyen 19, David Smith 19, Azim Ansari 19, Emily Dennis 3, Fleur Hudson 3, Eleanor J Barnes 19 20, Ann Sarah Walker 3
|
|
|
|
|
|
|
|
|
146. | Drug-Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study |
|
Int J Environ Res Public Health. 2021 Jul 3;18(13):7144.doi: 10.3390/ijerph18137144.
Alessandra Mangia 1, Francesco Scaglione 2, Pierluigi Toniutto 3, Mario Pirisi 4, Nicola Coppola 5, Giovanni Di Perri 6, Gema Alvarez Nieto 7, Stefano Calabrese 7, Candido Hernandez 8, Valentina Perrone 9, Luca Degli Esposti 9, Stefano Fagiuoli 10
|
|
|
147. | Prospective cohort study of children exposed to hepatitis C virus through a pregnancy screening program |
|
Int J Infect Dis. 2021 Sep;110:62-68. doi: 10.1016/j.ijid.2021.07.019. Epub 2021 Jul 14.
Raquel Borges Pinto 1, Ana Regina L Ramos 1, Leidy Tovar Padua 2, Emma Jane Swayze 3, Mary Catherine Cambou 4, Maristela Fiorini 5, Marineide Melo 6, Breno Riegel Santos 6, Ivete Cristina Teixeira Canti 6, Mara Liane Rieck Silveira 6, Maria Inês Gonzalez Solari 7, Juliana Ferraz de Correa 7, Kara Chew 4, Ivana Rosângela Dos Santos Varella 6, Karin Nielsen-Saines 8
|
|
|
|
|
|
|
150. | Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort |
|
Int J Drug Policy. 2021 Oct;96:103422.doi: 10.1016/j.drugpo.2021.103422. Epub 2021 Aug 21.
Joanne M Carson 1, Behzad Hajarizadeh 2, Josh Hanson 3, James O'Beirne 4, David Iser 5, Phillip Read 6, Anne Balcomb 7, Jane Davies 8, Joseph S Doyle 9, Jasmine Yee 2, Marianne Martinello 10, Philippa Marks 2, Gregory J Dore 11, Gail V Matthews 11, REACH-C Study Group
|
|
|
|
|
152. | A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community-based testing campaign |
|
J Viral Hepat. 2021 Nov;28(11):1624-1634.doi: 10.1111/jvh.13596. Epub 2021 Aug 28.
Anna Y Palmer 1, Kico Chan 1, Judy Gold 1 2, Chloe Layton 1, Imogen Elsum 1, Margaret Hellard 1 2 3 4 5, Mark Stoove 1 2, Joseph S Doyle 1 3, Alisa Pedrana 1 2, Nick Scott 1 2, on the EC Partnership
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
159. | High Cure Rates for Hepatitis C Virus Genotype 6 in Advanced Liver Fibrosis With 12 Weeks Sofosbuvir and Daclatasvir: The Vietnam SEARCH Study |
|
Open Forum Infect Dis. 2021 Jun 9;8(7):ofab267. doi: 10.1093/ofid/ofab267. eCollection 2021 Jul.
Barnaby Flower 1 2, Leanne McCabe 3, Chau Le Ngoc 1, Hung Le Manh 4, Phuong Le Thanh 4, Thuan Dang Trong 4, Thu Vo Thi 1, Hang Vu Thi Kim 1, Thanh Nguyen Tat 1, Dao Phan Thi Hong 1, An Nguyen Thi Chau 1, Tan Dinh Thi 1, Nga Tran Thi Tuyet 1, Joel Tarning 5, Cherry Kingsley 2, Evelyne Kestelyn 1, Sarah L Pett 3, Guy Thwaites 1, Vinh Chau Nguyen Van 4, David Smith 6, Eleanor Barnes 6, M Azim Ansari 6, Hugo Turner 7, Motiur Rahman 1, Ann Sarah Walker 2, Jeremy Day 1, Graham S Cooke 2
|
|
|
|
|
|
|
162. | Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study |
|
J Viral Hepat. 2021 Nov;28(11):1604-1613. doi: 10.1111/jvh.13587. Epub 2021 Oct 1.
Viola Knop 1, Daniel Hoppe 1 2, Johannes Vermehren 1, Sven Troetschler 1 3, Eva Herrmann 4, Annika Vermehren 1, Mireen Friedrich-Rust 1, Christoph Sarrazin 1 5, Jonel Trebicka 1, Stefan Zeuzem 1, Martin-Walter Welker 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
169. | High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence |
|
Am J Gastroenterol. 2021 Sep 1;116(9):1896-1904. doi: 10.14309/ajg.0000000000001332.
Philippe J Zamor 1, Ashley Brown 2, Douglas E Dylla 3, John F Dillon 4, Anne F Luetkemeyer 5, Jordan J Feld 6, David Mutimer 7, Reem Ghalib 8, Eric Crown 3, Sandra S Lovell 3, Yiran Hu 3, Christophe Moreno 9, David R Nelson 10, Massimo Colombo 11, Georgios Papatheodoridis 12, Juergen K Rockstroh 13, Richard Skoien 14, Eric Lawitz 15, Ira M Jacobson 16
|
|
|
170. | Strategies To Maximize Study Retention And Limit Attrition Bias In A Prospective Cohort Study Of Men Reporting A History Of Injecting Drug Use Released From Prison: The Prison And Transition Health Study |
|
Ashleigh Cara Stewart 1 2, Reece Cossar 3 4, Shelley Walker 3, Anna Lee Wilkinson 3 5, Brendan Quinn 3 5, Paul Dietze 3 5 6, Rebecca Winter 3 7, Amy Kirwan 3, Michael Curtis 3 5 8, James R P Ogloff 4, Stuart Kinner 5 9 10 11 12, Campbell Aitken 3 5, Tony Butler 13, Emma Woods 3, Mark Stoové 3 5
|
|
|
|
|
172. | Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation |
|
Ann Surg. 2021 Oct 1;274(4):613-620. doi: 10.1097/SLA.0000000000005070.
Michael K Turgeon 1, Shimul A Shah 2, Aaron M Delman 2, Benjamin V Tran 3, Vatche G Agopian 3, Joel P Wedd 1, Joseph F Magliocca 1, Ahyoung Kim 4, Andrew Cameron 4, Ali Olyaei 5, Susan L Orloff 5, Matthew P Anderson 6, Chandrashekhar A Kubal 6, Robert M Cannon 7, Jayme E Locke 7, Mary A Simpson 8, Mohamed E Akoad 8, Chelsey P Wongjirad 9, Juliet Emamaullee 9, Amika Moro 10, Federico Aucejo 10, Cyrus A Feizpour 11, Parsia A Vagefi 11, Mindie H Nguyen 12, Carlos O Esquivel 12, Kiran Dhanireddy 13, Vijay Subramanian 13, Alejandro Chavarriaga 14, Marwan M Kazimi 14, Maia S Anderson 15, Christopher J Sonnenday 15, Steven C Kim 16, David P Foley 16, Marwan Abdouljoud 17, Reena J Salgia 17, Dimitrios Moris 18, Debra L Sudan 18, Swaytha R Ganesh 19, Abhinav Humar 19, Majella Doyle 20, William C Chapman 20, Shishir K Maithel 1
|
|
|
|
|
|
|
175. | Non-adherence to LDV/SOF did not predict SVR in a randomized controlled trial of HIV/HCV coinfected persons who use drugs |
|
Infect Dis. 2021 Sep 20;jiab477. doi: 10.1093/infdis/jiab477.
Kathleen M Ward 1, Oluwaseun Falade-Nwulia 1, Juhi Moon 1, Catherine G Sutcliffe 2, Sherilyn Brinkley 1, Taryn Haselhuhn 1, Stephanie Katz 1, Kayla Herne 1, Lilian Arteaga 1, Shruti H Mehta 2, Carl Latkin 3, Robert K Brooner 4, Mark S Sulkowski 1
|
|
|
176. | Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis |
|
Liver Int. 2021 Sep 30. doi: 10.1111/liv.15074. Online ahead of print.
Mawuena Binka 1, Sofia Bartlett 1 2, Héctor A Velásquez García 1, Maryam Darvishian 3, Dahn Jeong 1 4, Prince Adu 1 4, Maria Alvarez 1, Stanley Wong 1, Amanda Yu 1, Hasina Samji 1 5, Mel Krajden 1 2, Jason Wong 1 4, Naveed Z Janjua 1 4
|
|
|
|
|
178. | Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study |
|
J Viral Hepat. 2021 Sep 28. doi: 10.1111/jvh.13617. Online ahead of print.
Valerio Rosato 1, Antonio Ascione 2, Riccardo Nevola 3, Anna Ludovica Fracanzani 4, Guido Piai 5, Vincenzo Messina 6, Ernesto Claar 1, Carmine Coppola 7, Luca Fontanella 2, Rosa Lombardi 4, Laura Staiano 7, Giovanna Valente 5, Maria Chiara Fascione 3, Chiara Giorgione 3, Annalisa Mazzocca 3, Raffaele Galiero 3, Pasquale Perillo 1, Aldo Marrone 3, Ferdinando Carlo Sasso 3, Luigi Elio Adinolfi 3, Luca Rinaldi 3
|
|
|
|
|
180. | Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study |
|
Dig Liver Dis. 2021 Sep 27;S1590-8658(21)00776-3. doi: 10.1016/j.dld.2021.09.007.Online ahead of print.
Vincenza Calvaruso 1, Salvatore Petta 2, Donatella Ferraro 3, Claudia La Mantia 2, Gerlando Gibilaro 2, Giada Reina 2, Velia Chiara Di Maio 4, Anna Licata 5, Francesca Ceccherini-Silberstein 4, Vito Di Marco 2, Antonio Craxì 2
|
|
|
181. | Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals |
|
Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. doi: 10.1158/1055-9965.EPI-21-0742.Online ahead of print.
Jennifer O Lam 1, Leo B Hurley 2, Jennifer B Lai 3, Varun Saxena 4 5, Suk Seo 6 7, Scott Chamberland 8, Charles P Quesenberry Jr 2, Jamila H Champsi 4, Joanna Ready 9, Elizabeth Y Chiao 10 11 12, Julia L Marcus # 13, Michael J Silverberg # 2
|
|
|
|
|
|
|
|
|
185. | Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals |
|
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):643-656.doi: 10.1080/17474124.2021.1877136. Epub 2021 Feb 15.
Riccardo Nevola 1, Luca Rinaldi 1, Letizia Zeni 1, Ciro Romano 1, Aldo Marrone 1, Raffaele Galiero 1, Pia Clara Pafundi 1, Carlo Acierno 1, Erica Vetrano 1, Luigi Elio Adinolfi 1
|
|
|
186. | Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs |
|
J Hepatol. 2021 Oct 8;S0168-8278(21)02103-6. doi: 10.1016/j.jhep.2021.09.038.Online ahead of print.
Alan Yeung 1, Norah E Palmateer 2, John F Dillon 3, Scott A McDonald 2, Shanley Smith 2, Stephen Barclay 4, Peter C Hayes 5, Rory N Gunson 6, Kate Templeton 7, David J Goldberg 8, Matthew Hickman 9, Sharon J Hutchinson 2
|
|
|
187. | Turning the tide on hepatitis C-related liver transplantation: the return on investment in hepatitis C treatment in Australia and New Zealand |
|
Liver Transpl. 2021 Oct 8. doi: 10.1002/lt.26329. Online ahead of print.
Jess Howell 1 2 3 4, Avik Majumdar 5 6, Michael Fink 7 8, Mandy Byrne 7, Geoff McCaughan 5 6, Simone I Strasser 5 6, Michael Crawford 5 6, Peter Hodgkinson 9, Katherine A Stuart 9, Caroline Tallis 9, John Chen 10, Alan Wigg 10, Robert Jones 7 8, Bryon Jaques 11, Gary Jeffrey 11 12, Leon Adams 11 12, Michael C Wallace 11 12, Stephen Munn 13, Ed Gane 13 14, Alex Thompson 1 2, Paul Gow 1 7
|
|
|
|
|
189. | BMS-986263 in Patients with Advanced Hepatic Fibrosis: 36-Week Results from a Randomized, Placebo-Controlled Phase 2 Trial |
|
Hepatology. 2021 Oct 4. doi: 10.1002/hep.32181. Online ahead of print.
Eric J Lawitz 1, Diane E Shevell 2, Giridhar S Tirucherai 2, Shuyan Du 2, Warner Chen 2, Uma Kavita 2, Angie Coste 1, Fred Poordad 1, Morten Karsdal 3, Mette Nielsen 3, Zachary Goodman 4, Edgar D Charles 2
|
|
|
|
|
191. | Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure |
|
Nat Commun. 2021 Oct 20;12(1):6105. doi: 10.1038/s41467-021-25649-6.
David A Smith 1, Carlota Fernandez-Antunez 2, Andrea Magri 1, Rory Bowden 3, Nimisha Chaturvedi 4, Jacques Fellay 4 5 6, John McLauchlan 7, Graham R Foster 8, William L Irving 9, STOP-HCV Consortium; Peter Simmonds 1, Vincent Pedergnana 10, Santseharay Ramirez 2, Jens Bukh 2, Eleanor Barnes 1, M Azim Ansari 11 12
|
|
|
|
|
|
|
194. | Incidence of liver and non-liver-related outcomes in patients with HCV-cirrhosis after SVR |
|
J Hepatol. 2021 Sep 27;S0168-8278(21)02043-2. doi: 10.1016/j.jhep.2021.09.013.Online ahead of print.
Roberta D'Ambrosio 1, Elisabetta Degasperi 2, Maria Paola Anolli 2, Ilaria Fanetti 2, Marta Borghi 2, Roberta Soffredini 2, Massimo Iavarone 2, Giulia Tosetti 2, Riccardo Perbellini 2, Angelo Sangiovanni 2, Vana Sypsa 3, Pietro Lampertico 4
|
|
|
195. | Clinical and Financial Implications of 2 Treatment Strategies for Donor-derived Hepatitis C Infections |
|
Transplant Direct. 2021 Sep 7;7(10):e762. doi: 10.1097/TXD.0000000000001222.eCollection 2021 Oct.
Zoe A Stewart 1, Jeffrey Stern 1, Nicole M Ali 1, Harmit S Kalia 1, Karen Khalil 1, Srijana Jonchhe 1, Elaina P Weldon 1, Rebecca A Dieter 1, Tyler C Lewis 1, Nur Funches 1, Sudara Crosby 1, Monique Seow 1, Jonathan C Berger 1, Nabil N Dagher 1, Bruce E Gelb 1, Anthony C Watkins 1, Nader Moazami 1, Deane E Smith 1, Zachary N Kon 2, Stephanie H Chang 1, Alex Reyentovich 1, Luis F Angel 1, Robert A Montgomery 1, Bonnie E Lonze 1
|
|
|
196. | Kidney Transplantation From Hepatitis C Viremic Deceased Donors to Aviremic Recipients in a Real-world Setting |
|
Transplant Direct. 2021 Sep 7;7(10):e761. doi: 10.1097/TXD.0000000000001217.eCollection 2021 Oct.
Beatrice P Concepcion 1, Laura A Binari 1, Heidi Schaefer 1, Scott Rega 2, Irene Feurer 2, Saed Shawar 1, Ruchi Naik 3, Laura Hickman 4, Jasmine Walker 4, Meghan Kapp 5, Kelly A Birdwell 1, Anthony Langone 1, J Harold Helderman 1, Bonnie Ann Sarrell 1, Guneet Kochar 1, Bernard Dubray 4, Kristin Smith 6, Heather O'Dell 6, April DeMers 6, Princess Shelton 6, Roman Perri 7, David Shaffer 4, Rachel C Forbes 4
|
|
|
|
|
|
|
|
|
200. | Disparities in Treatment with Direct-Acting Hepatitis C Virus Antivirals Persist Among Adults Coinfected with HIV and Hepatitis C Virus in US Clinics, 2010-2018 |
|
AIDS Patient Care STDS. 2021 Oct;35(10):392-400. doi: 10.1089/apc.2021.0087.
Gina M Simoncini 1, Qingjiang Hou 2, Kimberly Carlson 2, Kate Buchacz 3, Ellen Tedaldi 1, Frank Palella , Jr 4, Marcus Durham 3, Jun Li 3, HIV Outpatient Study (HOPS) Investigators
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
208. | Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly |
|
J Med Chem. 2021 Jul 8;64(13):9431-9443. doi: 10.1021/acs.jmedchem.1c00696.Epub 2021 Jun 29.
Adam Rolt 1, Daniel C Talley 2, Seung Bum Park 1, Zongyi Hu 1, Andrés Dulcey 2, Christopher Ma 1, Parker Irvin 1, Madeleine Leek 1, Amy Q Wang 2, Andrew V Stachulski 3, Xin Xu 2, Noel Southall 2, Marc Ferrer 2, T Jake Liang 1, Juan J Marugan 2
|
|
|
|
|
|
|
|
|
|
|
213. | Eradication of Chronic HCV Infection: Improvement of Dysbiosis Only in Patients Without Liver Cirrhosis |
|
Hepatology. 2021 Jul;74(1):72-82. doi: 10.1002/hep.31700. Epub 2021 Jun 15.
Freya Wellhöner 1, Nico Döscher 1, Franziska Woelfl 1, Marius Vital 2, Iris Plumeier 2, Silke Kahl 2, Andrej Potthoff 1, Michael Peter Manns 1 3, Dietmar Helmut Pieper 2 3, Markus Cornberg 1 3, Heiner Wedemeyer 1 3, Benjamin Heidrich 1 2 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
223. | HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago |
|
J Public Health (Oxf). 2021 Jun 22;fdab190. doi: 10.1093/pubmed/fdab190. Online ahead of print.
Sandra Tilmon 1, A Aronsohn 2, B Boodram 3, L Canary 4, S Goel 5, T Hamlish 6, S Kemble 7, D S Lauderdale 8, J Layden 9, K Lee 1, A J Millman 4, N Nelson 4, K Ritger 10, I Rodriguez 1, N Shurupova 11, J Wolf 12, D Johnson 1
|
|
|
|
|
|
|
226. | Is elimination of HCV in 2030 realistic in Central Europe |
|
Liver Int. 2021 Jun;41 Suppl 1:56-60. doi: 10.1111/liv.14834.
Robert Flisiak 1, Dorota Zarebska-Michaluk 2, Sona Frankova 3, Ivica Grgurevic 4, Bela Hunyady 5, Peter Jarcuska 6, Limas Kupcinskas 7, Michael Makara 8, Marieta Simonova 9, Jan Sperl 3, Ieva Tolmane 10, Adriana Vince 11
|
|
|
|
|
228. | Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era |
|
New Microbiol. 2021 Apr;44(2):89-94. Epub 2021 May 21.
Barbara Rossetti 1, Elisabetta Loggi 2 3, Chiara Spertilli Raffaelli 4, Simona Mercinelli 1, Claudia Gandolfo 5, Gianni Gori Savellini 5, Silvia Galli 6, Giovanni Vitale 2 7, Roberto Di Donato 2, Ranka Vukotic 2, Elena Grandini 2, Marzia Margotti 2, Valeria Guarneri 2, Giuliano Furlini 6, Maria Carla Re 6, Andrea De Luca 1 4, Pietro Andreone 2 8, Claudio Galli 9, Maria Grazia Cusi 5
|
|
|
|
|
|
|
|
|
|
|
233. | Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers |
|
J Subst Abuse Treat. 2021 Aug;127:108421. doi: 10.1016/j.jsat.2021.108421. Epub 2021 Apr 21.
Andrew H Talal 1, Urmo Jaanimägi 2, Kathleen Davis 3, Jordan Bailey 4, Barbara M Bauer 2, Arpan Dharia 2, Saliyah George 5, Anthony McLeod 4, Karen Morton 6, Ann Nugent 5, Marija Zeremski 6, Amreen Dinani 5, Don C Des Jarlais 7, Ponni V Perumalswami 8, Jonathan N Tobin 6, Suzanne S Dickerson 9
|
|
|
234. | Developing and Piloting a Standardized European Protocol for Hepatitis C Prevalence Surveys in the General Population (2016-2019) |
|
Front Public Health. 2021 May 28;9:568524. doi: 10.3389/fpubh.2021.568524. eCollection 2021.
Ida Sperle 1 2, Stine Nielsen 3, Viviane Bremer 1, Martyna Gassowski 1, Henrikki Brummer-Korvenkontio 4, Roberto Bruni 5, Anna Rita Ciccaglione 5, Elena Kaneva 6, Kirsi Liitsola 4, Zlatina Naneva 6, Tanya Perchemlieva 6, Enea Spada 5, Salla E Toikkanen 4, Andrew J Amato-Gauci 7, Erika Duffell 7, Ruth Zimmermann 1
|
|
|
235. | The impact of current opioid agonist therapy on hepatitis C virus treatment initiation among people who use drugs from in the DAA era: A population-based study |
|
Clin Infect Dis. 2021 Jun 14;ciab546. doi: 10.1093/cid/ciab546. Online ahead of print.
Sofia R Bartlett 1 2, Stanley Wong 1, Amanda Yu 1, Margo Pearce 1 3, Julia MacIsaac 4, Susan Nouch 5 6, Prince Adu 1 3, James Wilton 1, Hasina Samji 1 7, Emilia Clementi 1 3, Hector Velasquez 1, Dahn Jeong 1 3, Mawuena Binka 1, Maria Alvarez 1, Jason Wong 1 3, Jane Buxton 1 3, Mel Krajden 1 2, Naveed Z Janjua 1 3
|
|
|
|
|
|
|
|
|
239. | "Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era |
|
Transplant Direct. 2021 Jun 8;7(7):e707. doi: 10.1097/TXD.0000000000001154.eCollection 2021 Jul.
Thomas G Cotter 1, Jennifer Wang 1, Sarah R Lieber 2, Matthew A Odenwald 1, Nicole E Rich 2, Jorge A Marrero 2, Amit G Singal 2, Mack C Mitchell 2, Andrew Aronsohn 1, Michael Charlton 1, John Fung 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249. | The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018 |
|
PLoS One. 2021 Jun 9;16(6):e0251635. doi: 10.1371/journal.pone.0251635. eCollection 2021.
Adriane Wynn 1, Samantha Tweeten 2, Eric McDonald 2, Wilma Wooten 2, Kimberley Lucas 3, Cassandra L Cyr 1, Maricris Hernandez 1, Franchesca Ramirez 4, Corey VanWormer 5, Scott Suckow 6, Christian B Ramers 7, Natasha K Martin 1
|
|
|
250. | Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S |
|
AIDS Behav. 2021 Jun 10;1-12. doi: 10.1007/s10461-021-03332-7. Online ahead of print.
Madeline C Frost 1 2, Elsa W Sweek 1, Elizabeth J Austin 1, Maria A Corcorran 3, Alexa M Juarez 3, Noah D Frank 3, Stephanie M Prohaska 4, Paul A LaKosky 4, Alice K Asher 5, Dita Broz 6, Don C Des Jarlais 7, Emily C Williams 1 2, Sara N Glick 8
|
|
|
|
|
|
|
|
|
254. | Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic |
|
Am J Prev Med. 2021 May 10;S0749-3797(21)00220-8. doi: 10.1016/j.amepre.2021.03.011.Online ahead of print.
Harvey W Kaufman 1, Lara Bull-Otterson 2, William A Meyer 3rd 3, Xiaohua Huang 3, Mona Doshani 4, William W Thompson 4, Ademola Osinubi 4, Mohammed A Khan 4, Aaron M Harris 4, Neil Gupta 4, Michelle Van Handel 4, Carolyn Wester 4, Jonathan Mermin 4, Noele P Nelson 4
|
|
|
|
|
|
|
|
|
|
|
259. | Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience |
|
Am J Gastroenterol. 2021 Jun 1;116(6):1248-1255.doi: 10.14309/ajg.0000000000001147.
Luca Rinaldi 1, Vincenzo Messina 2, Vito Di Marco 3, Vincenzo Iovinella 4, Ernesto Claar 5, Giuseppe Cariti 6, Rodolfo Sacco 7, Massimo De Luca 8, Gaetano Scifo 9, Pietro Gatti 10, Giorgio Barbarini 11, Valeria Pace Palitti 12, Mariano Quartini 13, Paolo Tundo 14, Gianpiero D'Offizi 15, Giustino Parruti 16, Maria Antonietta di Rosolini 17, Giovanni Garrucciu 18, Lucio Cosco 19, Francesco Benanti 20, Giancarlo Gimignani 21, Umberto Vespasiani Gentilucci 22, Francesco Di Lorenzo 23, Maria D'Antò 24, Riccardo Nevola 1, Tommaso Lupia 6, Valerio Rosato 5, Valeria Morbiducci 13, Ilaria Luzzitelli 15, Federica Sozio 16, Marco Di Stefano 9, Emanuela Ciraci 10, Fabio Bulla 19, Riccardo Guarisco 21, Cecilia Cangiano 1, Michele Imparato 25, Paolo Maggi 2, Antonio Ascione 25, Antonio Craxì 3, Antonio Izzi 26
|
|
|
|
|
261. | Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence: A Systematic Review and Meta-analysis |
|
JAMA Psychiatry. 2021 Jun 2;e210976. doi: 10.1001/jamapsychiatry.2021.0976.Online ahead of print.
Thomas Santo Jr 1, Brodie Clark 1, Matt Hickman 2, Jason Grebely 3, Gabrielle Campbell 1 4, Luis Sordo 5 6, Aileen Chen 1 7, Lucy Thi Tran 1, Chrianna Bharat 1, Prianka Padmanathan 2, Grainne Cousins 8, Julie Dupouy 9 10, Erin Kelty 11, Roberto Muga 12, Bohdan Nosyk 13 14, Jeong Min 13, Raimondo Pavarin 15 16, Michael Farrell 1, Louisa Degenhardt 1
|
|
|
|
|
|
|
264. | "It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis C |
|
Int J Drug Policy. 2021 May 28;97:103280. doi: 10.1016/j.drugpo.2021.103280.Online ahead of print.
Shelley Walker 1, Jack Wallace 2, Ned Latham 2, Freya Saich 2, Alisa Pedrana 3, Margaret Hellard 4, Carla Treloar 5, Tafireyi Marukutira 2, Peter Higgs 6, Joseph Doyle 7, Mark Stoové 3
|
|
|
265. | Effectiveness of the HCV blood screening strategy through eighteen years of surveillance of HCV infection in blood donors in France |
|
Blood Transfus. 2021 May 12. doi: 10.2450/2021.0032-21. Online ahead of print.
Pierre Cappy 1, Laure Boizeau 1, Daniel Candotti 1, Rémi Caparros 1, Quentin Lucas 1, Eliane Garrabe 2, Christophe Martinaud 2, Sophie Le Cam 3, Pierre Gallian 3 4, Pascal Morel 3 5, Josiane Pillonel 6, Syria Laperche 1
|
|
|
266. | Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 |
|
Infez Med. 2021 Jun 1;29(2):242-251.
Barbara Rossetti 1, Lorenzo Paglicci 2, Velia C Di Maio 3, Chiara Cassol 2, Silvia Barbaliscia 3, Stefania Paolucci 4, Bianca Bruzzone 5, Nicola Coppola 6, Francesca Montagnani 2, Valeria Micheli 7, Laura Monno 8, Giacomo Zanelli 2, Teresa Santantonio 9, Nunzia Cuomo 10, Cinzia Caudai 11, Maurizio Zazzi 12, Francesca Ceccherini-Silberstein 3, C On Behalf Of The Hcv Virology Italian Resistance Network Vironet
|
|
|
267. | Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV) |
|
PLoS Med. 2021 Jun 1;18(6):e1003653. doi: 10.1371/journal.pmed.1003653.eCollection 2021 Jun.
Lars T Fadnes 1 2, Christer Frode Aas 1 2, Jørn Henrik Vold 1 2, Rafael Alexander Leiva 3, Christian Ohldieck 1, Fatemeh Chalabianloo 1 2, Svetlana Skurtveit 4 5, Ole Jørgen Lygren 1 6, Olav Dalgård 7 8, Peter Vickerman 9, Håvard Midgard 7 10, Else-Marie Løberg 1 11 12, Kjell Arne Johansson 1 2, INTRO-HCV Study Group
|
|
|
|
|
|
|
|
|
271. | Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes |
|
Nutr Metab Cardiovasc Dis. 2021 May 1;S0939-4753(21)00186-1.doi: 10.1016/j.numecd.2021.04.016. Online ahead of print.
Ferdinando Carlo Sasso 1, Pia Clara Pafundi 2, Alfredo Caturano 2, Raffaele Galiero 2, Erica Vetrano 2, Riccardo Nevola 2, Salvatore Petta 3, Anna Ludovica Fracanzani 4, Carmine Coppola 5, Vito Di Marco 3, Antonio Solano 6, Rosa Lombardi 4, Mauro Giordano 2, Antonio Craxi 3, Alessandro Perrella 7, Celestino Sardu 2, Raffaele Marfella 2, Teresa Salvatore 8, Luigi Elio Adinolfi 2, Luca Rinaldi 9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
278. | Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts |
|
Adv Ther. 2021 Jun;38(6):3409-3426. doi: 10.1007/s12325-021-01753-3. Epub 2021 May 22.
Xavier Forns 1, Jordan J Feld 2, Douglas E Dylla 3, Stanislas Pol 4, Kazuaki Chayama 5, Jinlin Hou 6, Jeong Heo 7, Pietro Lampertico 8 9, Ashley Brown 10, Mark Bondin 3, Fernando Tatsch 3, Margaret Burroughs 3, John Marcinak 3, Zhenzhen Zhang 3, Amanda Emmett 3, Stuart C Gordon 11, Ira M Jacobson 12
|
|
|
|
|
|
|
281. | Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection |
|
J Hepatol. 2021 May 20;S0168-8278(21)00336-6. doi: 10.1016/j.jhep.2021.04.056.Online ahead of print.
Gail V Matthews 1, Sanjay Bhagani 2, Marc Van der Valk 3, Juergen Rockstroh 4, Jordan J Feld 5, Andri Rauch 6, Christine Thurnheer 6, Julie Bruneau 7, Arthur Kim 8, Margaret Hellard 9, David Shaw 10, Ed Gane 11, Mark Nelson 12, Patrick Ingiliz 13, Tanya L Applegate 14, Jason Grebely 14, Phillipa Marks 14, Marianne Martinello 14, Kathy Petoumenos 14, Gregory J Dore 15, REACT study group; Protocol Steering Committee; Marc van der Valk 16, Margaret Hellard 17, Ed Gane 11, Andri Rauch 18, Julie Bruneau 7, Arthur Kim 19, Sanjay Bhagani 20, Greg Dore 21, Pip Marks 22, Gail Matthews 22, Jason Grebely 22, Kathy Petoumenos 22, Marianne Martinello 22, Tanya Applegate 22, Jordan Feld 23, Jürgen Rockstroh 4, Coordinating Centre; Site Principal Investigators
Collaborators
- Gail Matthews 24, Pip Marks 24, Sophia Amjad 24, Elise Tu 24, Kathy Petoumenos 24, Mahshid Tamaddoni 24, Marc van der Valk 16, Margaret Hellard 17, Ed Gane 11, Maria Christine Thurnheer 18, Yvonne Gilleece 25, Julie Bruneau 7, Mark Nelson 26, Chris Fraser 27, Alberto Moriggia 28, Thomas Lutz 29, Juhi Moon 30, Phillip Read 31, Arthur Y Kim 19, Andrew Ustianowski 32, Christiane Cordes 33, David Shaw 10, Sanjay Bhagani 20, Joe Sasadeusz 34, Mark Hull 35, Greg Dore 21, Jordan Feld 23, Jürgen Rockstroh 4, Dominique Braun 36, Patrick Ingiliz 13
|
|
|
282. | Linkage of resistance-associated substitutions in GT1 sofosbuvir+NS5A inhibitor failures treated with glecaprevir/pibrentasvir |
|
J Hepatol. 2021 May 20;S0168-8278(21)00339-1. doi: 10.1016/j.jhep.2021.04.057.Online ahead of print.
Gary P Wang 1, Gretja L Schnell 2, Jens J Kort 3, Gurjit S Sidhu 4, Layla Schuster 4, Rakesh L Tripathi 2, Lois Larsen 2, Larry C Michael 5, Ken Bergquist 5, Ashley Magee 5, Chandni B Patel 4, Joan A Whitlock 4, Ryan Tamashiro 4, Joy A Peter 6, Michael W Fried 7, David R Nelson 8
|
|
|
|
|
|
|
|
|
286. | Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance Analysis for HCV Patients with Prior Failure to DAA Therapy |
|
J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13549. Online ahead of print.
David A Smith 1 2, Daniel Bradshaw 3, Jean Mbisa 3, Carmen F Manso 3, David Bibby 3, Josh Singer 4, Emma Thomson 4, Ana Filipe 4, Elihu Aranday-Cortes 4, M Azim Ansari 1, Anthony Brown 1, Emma Hudson 1, Jennifer Benselin 5, Brendan Healy 6, Phil Troke 7, John McLauchlan 4, Eleanor Barnes 1 2, William L Irving 5
|
|
|
|
|
|
|
|
|
290. | Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease |
|
Am J Gastroenterol. 2021 Apr;116(4):723-732. doi: 10.14309/ajg.0000000000000994.
Monica Pons 1, Salvador Augustin, Bernhard Scheiner, Maeva Guillaume, Matteo Rosselli, Susana G Rodrigues, Horia Stefanescu, Mang M Ma, Mattias Mandorfer, Mayka Mergeay-Fabre, Bogdan Procopet, Philipp Schwabl, Arnulf Ferlitsch, Georg Semmler, Annalisa Berzigotti, Emmanuel Tsochatzis, Christophe Bureau, Thomas Reiberger, Jaime Bosch, Juan G Abraldes, Joan Genescà
|
|
|
291. | Characteristics and Donation Outcomes of Potential Organ Donors Perceived to be at Increased Risk for Blood Borne Virus Transmission: an Australian Cohort Study 2010-2018 |
|
Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003715. Online ahead of print.
Karen M J Waller 1, Nicole L De La Mata, Brenda M Rosales, James A Hedley, Patrick J Kelly, Imogen K Thomson, Michael J O'Leary, Elena Cavazzoni, Vidiya Ramachandran, William D Rawlinson, Kate R Wyburn, Angela C Webster
|
|
|
|
|
|
|
|
|
295. | Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease |
|
Am J Gastroenterol. 2021 Apr;116(4):723-732. doi: 10.14309/ajg.0000000000000994.
Monica Pons 1, Salvador Augustin, Bernhard Scheiner, Maeva Guillaume, Matteo Rosselli, Susana G Rodrigues, Horia Stefanescu, Mang M Ma, Mattias Mandorfer, Mayka Mergeay-Fabre, Bogdan Procopet, Philipp Schwabl, Arnulf Ferlitsch, Georg Semmler, Annalisa Berzigotti, Emmanuel Tsochatzis, Christophe Bureau, Thomas Reiberger, Jaime Bosch, Juan G Abraldes, Joan Genescà
|
|
|
296. | Characteristics and Donation Outcomes of Potential Organ Donors Perceived to be at Increased Risk for Blood Borne Virus Transmission: an Australian Cohort Study 2010-2018 |
|
Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003715. Online ahead of print.
Karen M J Waller 1, Nicole L De La Mata, Brenda M Rosales, James A Hedley, Patrick J Kelly, Imogen K Thomson, Michael J O'Leary, Elena Cavazzoni, Vidiya Ramachandran, William D Rawlinson, Kate R Wyburn, Angela C Webster
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
310. | T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy |
|
Open Forum Infect Dis. 2021 Feb 18;8(4):ofab079.doi: 10.1093/ofid/ofab079.eCollection 2021 Apr.
Ann W N Auma 1, Carey Shive 1, Sofi Damjanovska 2, Corinne Kowal 2, Daniel E Cohen 3, Debika Bhattacharya 4, Beverly Alston-Smith 5, Melissa Osborne 2, Robert Kalayjian 2, Ashwin Balagopal 6, Mark Sulkowski 6, David Wyles 7, Donald D Anthony 1 2 8
|
|
|
|
|
|
|
313. | Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial |
|
Lancet Gastroenterol Hepatol. 2021 Apr 15;S2468-1253(21)00031-5.doi: 10.1016/S2468-1253(21)00031-5. Online ahead of print.
Isabelle Andrieux-Meyer 1, Soek-Siam Tan 2, Sombat Thanprasertsuk 3, Nicolas Salvadori 4, Caroline Menétrey 5, François Simon 5, Tim R Cressey 6, Hajjah Rosaida Hj Mohd Said 7, Muhammad Radzi Abu Hassan 8, Haniza Omar 2, Hoi-Poh Tee 9, Wah Kheong Chan 10, Suresh Kumar 11, Satawat Thongsawat 12, Kanawee Thetket 13, Anchalee Avihingsanon 14, Suparat Khemnark 15, Sabine Yerly 16, Nicole Ngo-Giang-Huong 17, Sasikala Siva 18, Alistair Swanson 5, Vishal Goyal 19, Francois Bompart 5, Bernard Pécoul 5, Shahnaz Murad 20
|
|
|
|
|
|
|
|
|
317. | Hepatitis C Virus Testing Among Men With Human Immunodeficiency Virus Who Have Sex With Men: Temporal Trends and Racial/Ethnic Disparities |
|
-
Open Forum Infect Dis. 2021 Apr 17;8(4):ofaa645. doi: 10.1093/ofid/ofaa645.eCollection 2021 Apr.
Jun Li 1, Carl Armon 2, Frank J Palella 3, Ellen Tedaldi 4, Richard M Novak 5, Jack Fuhrer 6, Gina Simoncini 4, Kimberly Carlson 2, Kate Buchacz 1, HIV Outpatient Study (HOPS) Investigators
Collaborators
- HIV Outpatient Study (HOPS) Investigators:
-
Jun Li, Kate Buchacz, Marcus D Durham, Cheryl Akridge, Stacey Purinton, Nabil Rayeed, Selom Agbobil-Nuwoaty, Kalliope Chagaris, Kimberly Carlson, Carl Armon, Linda Battalora, Jonathan Mahnken, Frank J Palella, Saira Jahangir, Conor Daniel Flaherty, Patricia Bustamante, John Hammer, Kenneth S Greenberg, Barbara Widick, Rosa Franklin, Douglas J Ward, Troy Thomas, Cheryl Stewart, Jack Fuhrer, Linda Ording-Bauer, Rita Kelly, Jane Esteves, Ellen M Tedaldi, Ramona A Christian, Faye Ruley, Dania Beadle, Princess Davenport, Richard M Novak, Andrea Wendrow, Stockton Mayer, Mia Scott, Billie Thomas, Loraine Van Slyke, Cynthia Mayer, Terry Beitler, Karen Maroney, Denise Franklin
|
|
|
|
|
319. | Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian 'surveillance and treatment of prisoners with hepatitis C' project (SToP-C) |
|
Harm Reduct J. 2021 Apr 26;18(1):46. doi: 10.1186/s12954-021-00494-4.
Jake Rance 1, Lise Lafferty 2, Carla Treloar 2, SToP-C Study Group
Collaborators
Stuart Loveday, Gregory Dore, Andrew Lloyd, Jason Grebely, Tony Butler, Natasha Martin, Georgina Chambers, Carla Treloar, Marianne Byrne, Roy Donnelly, Colette McGrath, Julia Bowman, Lee Trevethan, Luke Grant, Terry Murrell, Nicky Bath, Mary Harrod, Alison Churchill, Kate Pinnock, Sallie Cairnduff
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
329. | High hepatitis C virus seropositivity, viremia, and associated risk factors among trans women living in San Francisco, California |
|
PLoS One. 2021 Mar 30;16(3):e0249219. doi: 10.1371/journal.pone.0249219. eCollection 2021.
Christopher J Hernandez 1, Dillon Trujillo 1, Sofia Sicro 1, Joaquin Meza 1, Mackie Bella 1, Emperatriz Daza 1, Francisco Torres 1, Willi McFarland 1 2, Caitlin M Turner 1 2, Erin C Wilson 1 2
|
|
|
|
|
331. | Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in children with chronic hepatitis C virus: part 2 of the DORA study |
|
Hepatology. 2021 Apr 2. doi: 10.1002/hep.31841. Online ahead of print.
Maureen M Jonas 1, Susan Rhee 2, Deirdre A Kelly 3, Antonio Del Valle-Segarra 4, Cornelia Feiterna-Sperling 5, Susan Gilmour 6, Regino P Gonzalez-Peralta 7, Loreto Hierro 8, Daniel H Leung 9, Simon C Ling 10, Yuri Lobzin 11, Steven Lobritto 12, Tatsuki Mizuochi 13, Michael R Narkewicz 14, Vishakha Sabharwal 15, Jessica Wen 16, Hoi Kei Lon 2, John Marcinak 2, Andrew Topp 2, Rakesh Tripathi 2, Etienne Sokal 17
|
|
|
|
|
|
|
334. | Risk Factors Associated With Chronic Liver Enzyme Elevation in Persons With HIV Without Hepatitis B or C Coinfection in the Combination Antiretroviral Therapy Era |
|
Open Forum Infect Dis. 2021 Feb 24;8(3):ofab076. doi: 10.1093/ofid/ofab076.eCollection 2021 Mar.
Shannon Wood 1 2 3 4, Seung Hyun Won 3 5, Hsing-Chuan Hsieh 3 5, Tahaniyat Lalani 3 5 6, Karl Kronmann 3 6, Ryan C Maves 3 7, Gregory Utz 3 7, Christina Schofield 3 4, Rhonda E Colombo 3 5 4, Jason F Okulicz 3 8, Jason Blaylock 2 3, Brian K Agan 3 5, Anuradha Ganesan 2 3 5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
342. | Decreases in markers of monocyte/macrophage activation after hepatitis C eradication in HIV/HCV co-infected women |
|
AIDS. 2021 Mar 11. doi: 10.1097/QAD.0000000000002869. Online ahead of print.
Audrey L French 1, Dara Grennan, Elizabeth Daubert, Eric C Seaberg, Marion Peters, Michael Augenbraun, Margaret Fischl, Seble Kassaye, Ricardo Franco, Mark Kuniholm, Adaora A Adimora, Kimberly Workowski, Kathleen M Weber
|
|
|
|
|
|
|
|
|
346. | Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry |
|
Clin Infect Dis. 2021 Mar 2;ciaa1510. doi: 10.1093/cid/ciaa1510. Online ahead of print.
Fernanda Q Onofrio 1, Curtis Cooper 2, Sergio M Borgia 3, Marie-Louise Vachon 4, Alnoor Ramji 5, Leslie B Lilly 6, Alexander Wong 7, Joshua Booth 1, Izza Sattar 1, Heidy Morales 1, Samuel Lee 8, Brian Conway 9, Jordan J Feld 1
|
|
|
|
|
|
|
|
|
350. | HCV virology and diagnosis |
|
Clin Res Hepatol Gastroenterol. 2021 Feb 23;45(3):101626.doi: 10.1016/j.clinre.2021.101626. Online ahead of print.
Steven Roger 1, Alexandra Ducancelle 1, Hélène Le Guillou-Guillemette 1, Catherine Gaudy 2, Françoise Lunel 3
|
|
|
| | | | | |